ד"ר אנטון וול  מעורב באופן פעיל ויזום במספר רב מחקרים קליניים ומדעיים בתחום נוירוכירורגיה ונוירו-אונקולוגיה שבודקים השפעה של שיטות טיפול חדשניות על גידולי מוח ממאירים. 

Human cytomegalovirus in malignant brain gliomas , Israel, Sheba Medical Center (pub), 2010. 

Effects of peripheral blood-derived γ9δ2 T-cells from patients with GBM (pub.), Israel, Sheba Medical Center, 2013. 

Targeting of GBM by the loaded nanoparticles (pub.) Israel, Sheba Medical Center, 2014. 

Expression of Klotho protein in GBM. (pub.) Israel, Sheba Medical Center, collaboration with Tel Aviv Medical Center, 2013. 

Treatment strategy of GBM with PAR1- inhibitor. (pub.) Israel, Sheba Medical Center, 2015-2016. 

Effects of Apixaban in ischemic stroke in mice model. (pub.) Israel, Sheba Medical Center, 2016. 

Developing of animal model of DIPG H3K27 mutant tumor and its treatment strategies. (pub.) Mayo Clinic, Rochester, MN, US, 2016-2017. 

Epigenetic screening of small experimental molecules and treatment of various DIPG cell lines in vitro. Mayo Clinic, Rochester, MN, US, 2016-2017. 

Opening of Brain-Blood Barrier by the means of Focus Ultra Sound Technic in animal model. Israel, Sheba Medical Center collaboration with Insightec. 2019-2020. (pub.)   

Alpha Particles modulated intratumoral Radiation Therapy of 
recurrent High Grade Gliomas. Israel, Sheba Medical Center & 

Targeting therapy of Medulloblastoma (mice model). Israel, Sheba Medical Center, 2020- now.